ClinConnect ClinConnect Logo
Search / Trial NCT02263313

EGO-COMBO Clinical End-point Extension Study Beyond 36 Months

Launched by THE UNIVERSITY OF HONG KONG · Oct 7, 2014

Trial Information

Current as of July 22, 2025

Completed

Keywords

Safety And Efficacy Combo Stent Late Loss Thrombosis Late Loss Catch Up

ClinConnect Summary

The Genous Stent (the EPC Capture R-stent, OrbusNeich Medical Inc., Fort Lauderdale, FL) is commercially available and has been used extensively in standard coronary intervention in the treatment of more than 200 patients with critical coronary stenoses at Queen Mary Hospital. The COMBO Stent (OrbusNeich Medical Inc., Fort Lauderdale, FL) is an improved version of the Genous Stent and is now widely available for clinical use in all Hong Kong hospitals. To date, more than 300 patients in Queen Mary Hospital have received the COMBO stent as treatment for their coronary artery disease, and all...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient previously participated in EGO-COMBO Pilot Study (UW 10-342)
  • Exclusion Criteria:
  • Patient not previously participated in EGO-COMBO Pilot Study (UW 10-342)

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, Hong Kong, China

Patients applied

0 patients applied

Trial Officials

Wai Luen Stephen LEE, MD

Principal Investigator

The Univeristy of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials